These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38326132)
21. Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany. Geissler F; Hartmann F; Humphreys M; Klüver H; Giesecke J PLoS One; 2022; 17(12):e0278337. PubMed ID: 36516143 [TBL] [Abstract][Full Text] [Related]
22. Attitudes Toward the Global Allocation of Chinese COVID-19 Vaccines: Cross-sectional Online Survey of Adults Living in China. Yu H; Du R; Wang M; Yu F; Yang J; Jiao L; Wang Z; Liu H; Wu P; Bärnighausen T; Xue L; Wang C; McMahon S; Geldsetzer P; Chen S JMIR Public Health Surveill; 2022 Jun; 8(6):e33484. PubMed ID: 35483084 [TBL] [Abstract][Full Text] [Related]
23. Public opinion on COVID-19 vaccine prioritization in Bangladesh: Who gets the vaccine and whom do you leave out? Biswas RK; Afiaz A; Huq S; Farzana M; Kabir E Vaccine; 2023 Jul; 41(34):5018-5028. PubMed ID: 37407404 [TBL] [Abstract][Full Text] [Related]
24. Public attitudes about equitable COVID-19 vaccine allocation: a randomised experiment of race-based versus novel place-based frames. Schmidt H; Shaikh SJ; Sadecki E; Buttenheim A; Gollust S J Med Ethics; 2022 Dec; 48(12):993-999. PubMed ID: 35927020 [TBL] [Abstract][Full Text] [Related]
25. The Race for Global Equitable Access to COVID-19 Vaccines. Md Khairi LNH; Fahrni ML; Lazzarino AI Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194 [TBL] [Abstract][Full Text] [Related]
26. Evolution of Public Opinion on COVID-19 Vaccination in Japan: Large-Scale Twitter Data Analysis. Kobayashi R; Takedomi Y; Nakayama Y; Suda T; Uno T; Hashimoto T; Toyoda M; Yoshinaga N; Kitsuregawa M; Rocha LEC J Med Internet Res; 2022 Dec; 24(12):e41928. PubMed ID: 36343186 [TBL] [Abstract][Full Text] [Related]
27. A statistical look at the COVID-19 vaccine development and vaccine policies. Apio C; Han K; Heo G; Park T Front Public Health; 2022; 10():1048062. PubMed ID: 36544793 [TBL] [Abstract][Full Text] [Related]
28. Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization. Hayman B; Dennehy M Vaccine; 2021 Aug; 39(36):5153-5161. PubMed ID: 34362602 [TBL] [Abstract][Full Text] [Related]
29. COVAX, vaccine donations and the politics of global vaccine inequity. de Bengy Puyvallée A; Storeng KT Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116 [TBL] [Abstract][Full Text] [Related]
30. Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity. Park SP; Lee HJ; Yu Y; Lee EYJ; Park YS BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 38035734 [TBL] [Abstract][Full Text] [Related]
31. Can we move beyond vaccine apartheid? Examining the determinants of the COVID-19 vaccine gap. Forman L; Jackson C; Fajber K Glob Public Health; 2023 Jan; 18(1):2256822. PubMed ID: 37715686 [TBL] [Abstract][Full Text] [Related]
32. Divergent COVID-19 vaccine policies: Policy mapping of ten European countries. van Kessel R; Forman R; Milstein R; Mastylak A; Czabanowska K; Czypionka T; Durand-Zaleski I; Hirche A; Krysinska-Pisarek M; Maynou L; Roberts B; Torbica A; Vrangbæk K; Wang Y; Wouters OJ; Mossialos E Vaccine; 2023 Apr; 41(17):2804-2810. PubMed ID: 36967287 [TBL] [Abstract][Full Text] [Related]
34. Global health governance performance during Covid-19, what needs to be changed? a delphi survey study. Abu El Kheir-Mataria W; El-Fawal H; Chun S Global Health; 2023 Mar; 19(1):24. PubMed ID: 37004079 [TBL] [Abstract][Full Text] [Related]
35. A multinational Delphi consensus to end the COVID-19 public health threat. Lazarus JV; Romero D; Kopka CJ; Karim SA; Abu-Raddad LJ; Almeida G; Baptista-Leite R; Barocas JA; Barreto ML; Bar-Yam Y; Bassat Q; Batista C; Bazilian M; Chiou ST; Del Rio C; Dore GJ; Gao GF; Gostin LO; Hellard M; Jimenez JL; Kang G; Lee N; Matičič M; McKee M; Nsanzimana S; Oliu-Barton M; Pradelski B; Pyzik O; Rabin K; Raina S; Rashid SF; Rathe M; Saenz R; Singh S; Trock-Hempler M; Villapol S; Yap P; Binagwaho A; Kamarulzaman A; El-Mohandes A; Nature; 2022 Nov; 611(7935):332-345. PubMed ID: 36329272 [TBL] [Abstract][Full Text] [Related]
36. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. So AD; Woo J BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376 [TBL] [Abstract][Full Text] [Related]
37. How Do COVID-19 Vaccine Policies Affect the Young Working Class in the Philippines? Estoce RHY; Ngan OMY; Calderon PEE Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767960 [TBL] [Abstract][Full Text] [Related]
38. Global impact of vaccine nationalism during COVID-19 pandemic. Riaz MMA; Ahmad U; Mohan A; Dos Santos Costa AC; Khan H; Babar MS; Hasan MM; Essar MY; Zil-E-Ali A Trop Med Health; 2021 Dec; 49(1):101. PubMed ID: 34963494 [TBL] [Abstract][Full Text] [Related]
39. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries. Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840 [No Abstract] [Full Text] [Related]
40. Will access to COVID-19 vaccine in Aotearoa be equitable for priority populations? Whitehead J; Scott N; Carr PA; Lawrenson R N Z Med J; 2021 May; 134(1535):25-35. PubMed ID: 34012138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]